<DOC>
	<DOCNO>NCT02647918</DOCNO>
	<brief_summary>The purpose study evaluate effect mild , moderate , severe renal impairment , end-stage renal disease ( ESRD ) require hemodialysis ( HD ) , safety tolerability 1 2 single dos sotagliflozin compare healthy , demographically-matched subject normal renal function .</brief_summary>
	<brief_title>Study Evaluate Sotagliflozin Subjects With Varying Degrees Renal Function</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Adult male female subject ≥18 ≤75 year age Body mass index ≥18.0 ≤36.0 kg/m2 , Screening Subjects mild , moderate , severe renal impairment , ESRD require HD Control group match healthy subject Willing able provide write informed consent Presence clinically significant physical , laboratory , ECG finding may interfere aspect study conduct interpretation result Existence surgical medical condition might interfere absorption , distribution , metabolism , excretion sotagliflozin History major surgery within 6 month History hepatic disease , significantly abnormal liver function test Women breastfeed plan become pregnant study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>